Skip to main content

ADVERTISEMENT

Bradley P Knight, MD, FACC, FHRS Editor-in-Chief, EP Lab Digest

Letter from the Editor
05/29/2024
Bradley P Knight, MD, FACC, FHRS Editor-in-Chief, EP Lab Digest
It is surprising that in the latest atrial fibrillation guideline, not a single antiarrhythmic drug is considered to have a class I indication.
It is surprising that in the latest atrial fibrillation guideline, not a single antiarrhythmic drug is considered to have a class I indication.
It is surprising that in the...
05/29/2024
EP Lab Digest